Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 6/20 | 0.46 |
| ▸ | HSD11B2 | P80365 | 4/20 | 0.46 |
| ▸ | SSTR4 | P31391 | 10/20 | 0.45 |
| ▸ | SSTR1 | P30872 | 7/20 | 0.45 |
| ▸ | GHSR | Q92847 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2984736 | 0.93 | HSD11B1 (0.48) | HSD11B1HSD11B2SSTR4SSTR1CNR1 | |
| SCHEMBL2985243 | 0.85 | HSD11B1 (0.46) | HSD11B1HSD11B2SSTR4SSTR1CNR1 | |
| SCHEMBL2983482 | 0.81 | HSD11B1 (0.40) | HSD11B1HSD11B2SSTR4SSTR1 | |
| SCHEMBL2987254 | 0.81 | SSTR4 (0.41) | HSD11B1HSD11B2SSTR4SSTR1ALDH1A1 | |
| SCHEMBL2983411 | 0.79 | HSD11B1 (0.42) | HSD11B1HSD11B2SSTR4SSTR1CNR1 | |
| SCHEMBL4863362 | 0.77 | PPARA (0.53) | HSD11B1HSD11B2ALDH1A1MAPTHTT | |
| SCHEMBL2974336 | 0.74 | MEN1 (0.46) | ALDH1A1NPSR1 | |
| SCHEMBL2976744 | 0.73 | KDM4E (0.45) | ALDH1A1MAPTHTTNPSR1 | |
| SCHEMBL2989096 | 0.73 | ATF4 (0.58) | ALDH1A1LMNAHTTSMN1; SMN2 | |
| SCHEMBL4870410 | 0.73 | PPARA (0.53) | HSD11B1HSD11B2CNR1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | claimed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | claimed |
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | disclosed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | DPYD, PKD1, AOC1 | HSD11B1 829/4885HSD11B2 652/4885SSTR4 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.